Evaluation of a quantitative double ELISA strategy for confirmation and differentiation of HIV infection

Journal of Virological Methods

Volumn 66, Issue 2, 1997, Pages 203-209

  Rehle, T M ^a   Mattke, P ^c   Liomba, G N ^b   Kramer S ^c   Gershy Damet, G M ^d   Konan, K ^d   Sangare, A ^d   Zekeng, L ^e   Tsague, J M ^e   Kaptue, L ^e   Eberle, J ^a   Gurtler L ^a  

^a UNIVERSITY OF MUNICH   (Germany)

^b QUEEN ELIZABETH CENTRAL HOSPITAL   (Malawi)

^c Financial Systems Development Section   (Germany)

^d Prog Natl de Lutte contre le SIDA   (Côte d’Ivoire)

^e Centre Hospitalier et Universitaire de Yaounde   (Cameroon)

Author keywords

HIV 1 confirmation; HIV 1 group differentiation; Indirect and competitive ELISA; Quantitative ELISA

Indexed keywords

ANTIGEN SPECIFICITY; ARTICLE; BLOOD SAMPLING; CELL DIFFERENTIATION; DNA SEQUENCE; ENZYME LINKED IMMUNOSORBENT ASSAY; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; NONHUMAN; PRIORITY JOURNAL; SEROCONVERSION; VIRUS DETECTION; VIRUS TRANSMISSION;

HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS 2;

EID: 0030829303     PISSN: 01660934     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0166-0934(97)00058-X     Document Type: Article

References (20)

1. Arnold, C., Barlow, K.L., Parry, J.V., Clewley, J.P., 1995. At least five HIV-1 sequence subtypes (A, B, C,D, A/E) occur in England. AIDS Res. Human Retrovir. 11, 427-429
2. Barin, F., Kabeya, C.M., 1994. Diagnostic tools for HIVs. In: Essex, M., Mboup, S., Kanki, P.J., Kalengayi, M.R. (Eds.), AIDS in Africa, Raven Press, New York, pp. 109-131.
3. CDC, 1996. Identification of HIV-1 group O infection, Los Angeles County, California, 1996. Morb. Mortal. Weekly Rep. 45, 561-565
4. Charneau, P., Borman, A.M., Quillent, C., Guétard, D., Chamaret, S., Cohen, J., Rémy, G., Montagnier, L., Clavel, F., 1994. Isolation and enevelope sequence of a highly divergent HIV-1 isolate: definition of a new HIV-1 group. Virology 205, 247-253
5. Gürtler, L.G., Hauser, P.H., Eberle, J., von Brunn, A., Knapp, S., Zekeng, L., Tsague, J.M., Kaptue, L., 1994. A new subtype of human immunodeficiency virus type 1 (MVP-5180) from Cameroon. J. Virol. 68, 1581-1585.
6. Gürtler, L., 1996. Difficulties and strategies of HIV diagnosis. Lancet 348, 176-179.
7. Kabeya, C.M., Williams, E.E., Eni, E., Peeters, M., Saman, E., Delaporte, E., 1995. Evidence for HIV-1 group O infection in Nigeria. Lancet 346, 308.
8. Kunanusont, C., Foy, H.M., Kreiss, J.K., Ngarm, S.R., Phanuphak, P., Raktham, S., Pau, C.P., Yonug, N.L., 1995. HIV-1 subtypes and male-to-female transmission in Thailand. Lancet 345, 1078-1083.
9. Luo, C.C., Tian, C., Hu, D.J., Kai, M., Dondero, T.J., Zheng, X., 1995. HIV-1 subtype C in China. Lancet 345, 1051-1052.
10. Mastro, T.D., Kunanusont, C., Dondero, T.J., Wasi, C., 1997. Why do HIV-1 subtypes segregate among persons with different risk behaviors in South Africa and Thailand. AIDS 11, 113-116.
11. McCutchan, F.E., Salminen, M. O., Carr, J.K., Burke, D.S., 1996. HIV-1 genetic diversity. AIDS 10(Suppl. 3), S13-S20
12. Potts, K.E., Kalsih, M.L., Lott, T. et al., 1993. Genetic heterogeneity of the V3 region of the HIV-1 envelope glycoprotein in Brazil. AIDS 7, 1191-1197.
13. Sato, P.A., Maskill, W.J., Tamashiro, H., Heymann, D.L., 1994. Strategies for laboratory HIV testing: an examination of alternative approaches not requiring western blot. Bull. WHO 72, 129-134.
14. Schabte, C., Zekeng, L., Pau, C.P. et al., 1994. Sensitivity of the United States HIV antibody tests for detection of HIV-1 group O infections. Lancet 344, 1333-1334.
15. Sharp, P.M., Robertson, D.L., Gao, F., Hahn, B.H., 1994. Origins and diversity of human immunodeficiency viruses. AIDS 8(Suppl 1), S27-S42.
16. Simon, F., Ly, T.D., Baillou-Beaufils, A. et al., 1994. Sensitivity of screening kits for anti-HIV-1 subtype O antibodies. AIDS 8, 1628-1629.
17. Van der Groen, G., Van Kerckhoven, I., Vercauteren, G., Piot, P., 1991. Simplified and less expensive confirmatory HIV testing. Bull. WHO 69, 747-752.
18. WHO, 1990. Acquired immune deficiency syndrome (AIDS): Proposed WHO criteria for interpreting results from Western blot assays for HIV-1, HIV-2 and HTLV-I/HTLV-II. Wkly. Epidem. Rec. 65, 281-283.
19. WHO, 1994. The HIV/AIDS pandemic: 1994 overview. WHO/ GPA/TCO/SEF/94.4.
20. Zekeng, L., Gürtler, L., Afane Ze, E. et al., 1994. Prevalence of HIV-1 subtype O infection in Cameroon: preliminary results. AIDS, 8, 1626-1627.